Per Westermark

31.3k total citations · 8 hit papers
372 papers, 23.1k citations indexed

About

Per Westermark is a scholar working on Molecular Biology, Physiology and Surgery. According to data from OpenAlex, Per Westermark has authored 372 papers receiving a total of 23.1k indexed citations (citations by other indexed papers that have themselves been cited), including 264 papers in Molecular Biology, 131 papers in Physiology and 94 papers in Surgery. Recurrent topics in Per Westermark's work include Amyloidosis: Diagnosis, Treatment, Outcomes (214 papers), Alzheimer's disease research and treatments (121 papers) and Pancreatic function and diabetes (78 papers). Per Westermark is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (214 papers), Alzheimer's disease research and treatments (121 papers) and Pancreatic function and diabetes (78 papers). Per Westermark collaborates with scholars based in Sweden, United States and Norway. Per Westermark's co-authors include Gunilla T. Westermark, Knut Sletten, Kenneth H. Johnson, Erik Wilander, Timothy D. O’Brien, Giampaolo Merlini, Gibbons G. Cornwell, Christer Wernstedt, Ulla Engström and Arne Andersson and has published in prestigious journals such as New England Journal of Medicine, Chemical Reviews and Proceedings of the National Academy of Sciences.

In The Last Decade

Per Westermark

362 papers receiving 22.4k citations

Hit Papers

Amyloid fibrils in human insulinoma and islets of Langerh... 1987 2026 2000 2013 1987 2011 1990 1990 2016 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells.
    1987 816 citations Per Westermark, Erik Wilander et al. profile →
  2. Islet Amyloid Polypeptide, Islet Amyloid, and Diabetes Mellitus
    2011 812 citations Per Westermark, Arne Andersson et al. profile →
  3. Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation.
    1990 685 citations Per Westermark, Kenneth H. Johnson et al. profile →
  4. Fibril in senile systemic amyloidosis is derived from normal transthyretin.
    1990 549 citations Per Westermark, Knut Sletten et al. profile →
  5. Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines
    2016 438 citations Per Westermark et al. Amyloid profile →
  6. Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee
    2018 396 citations Per Westermark et al. Amyloid profile →
  7. Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee
    2020 268 citations Per Westermark et al. Amyloid profile →
  8. Amyloid nomenclature 2022: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee
    2022 184 citations Per Westermark et al. Amyloid profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Per Westermark Sweden 80 15.6k 9.2k 5.2k 3.4k 3.1k 372 23.1k
Phillip Görden United States 78 9.5k 0.6× 4.5k 0.5× 4.6k 0.9× 3.1k 0.9× 1.8k 0.6× 286 20.2k
Enrique Rozengurt United Kingdom 99 22.2k 1.4× 2.5k 0.3× 3.3k 0.6× 1.6k 0.5× 5.2k 1.7× 504 32.9k
Dudley K. Strickland United States 75 8.7k 0.6× 5.2k 0.6× 2.4k 0.5× 1.1k 0.3× 3.5k 1.1× 257 21.3k
Axel Kahn France 65 10.5k 0.7× 2.5k 0.3× 3.3k 0.6× 3.2k 0.9× 1.7k 0.6× 268 20.7k
Shaun R. Coughlin United States 88 10.5k 0.7× 1.6k 0.2× 2.5k 0.5× 1.4k 0.4× 2.2k 0.7× 181 30.8k
Roger J. Hajjar United States 90 17.5k 1.1× 1.8k 0.2× 4.3k 0.8× 3.0k 0.9× 1.3k 0.4× 500 28.9k
Gunilla T. Westermark Sweden 46 5.2k 0.3× 4.5k 0.5× 2.7k 0.5× 1.3k 0.4× 1.4k 0.5× 153 9.4k
Peter J. Parker United Kingdom 95 25.3k 1.6× 3.0k 0.3× 1.5k 0.3× 1.5k 0.5× 7.6k 2.5× 406 33.7k
Jan M. van Deursen United States 60 13.3k 0.9× 8.7k 0.9× 997 0.2× 1.5k 0.4× 3.5k 1.1× 116 26.1k
Edward J. Goetzl United States 94 13.6k 0.9× 6.2k 0.7× 1.7k 0.3× 885 0.3× 2.1k 0.7× 380 26.6k

Countries citing papers authored by Per Westermark

Since Specialization
Citations

This map shows the geographic impact of Per Westermark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Per Westermark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Per Westermark more than expected).

Fields of papers citing papers by Per Westermark

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Per Westermark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Per Westermark. The network helps show where Per Westermark may publish in the future.

Co-authorship network of co-authors of Per Westermark

This figure shows the co-authorship network connecting the top 25 collaborators of Per Westermark. A scholar is included among the top collaborators of Per Westermark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Per Westermark. Per Westermark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tzortzakakis, Antonios, et al.. (2025). Cardiac amyloidosis after lumbar spinal stenosis surgery – a comprehensive prospective cohort study. Amyloid. 32(3). 218–225. 1 indexed citations
2.
Westermark, Gunilla T., et al.. (2025). The question of strains in AA amyloidosis. Scientific Reports. 15(1). 3684–3684.
3.
Westermark, Per, et al.. (2023). Regionalization of cell types in silk glands of Larinioides sclopetarius suggest that spider silk fibers are complex layered structures. Scientific Reports. 13(1). 22273–22273. 5 indexed citations
4.
Canetti, Diana, Nigel B. Rendell, Janet A. Gilbertson, et al.. (2021). Clinical ApoA‐IV amyloid is associated with fibrillogenic signal sequence. The Journal of Pathology. 255(3). 311–318. 8 indexed citations
5.
Solomon, Alan, Charles L. Murphy, & Per Westermark. (2008). Unreliability of immunohistochemistry for typing amyloid deposits.. Archives of Pathology & Laboratory Medicine. 132(1). 14–14. 35 indexed citations
6.
Linke, Reinhold P., Charles L. Murphy, Hui Zhou, et al.. (2005). Senile seminal vesicle amyloid is derived from semenogelin I. Journal of Laboratory and Clinical Medicine. 145(4). 187–193. 37 indexed citations
7.
Vahlquist, Anders, Agneta Gånemo, Maritta Hellström Pigg, Marie Virtanen, & Per Westermark. (2003). The Clinical Spectrum of Congenital Ichthyosis in Sweden: A Review of 127 Cases. Acta Dermato Venereologica. 83(213). 34–47. 22 indexed citations
8.
Murphy, Charles L., Manfred Eulitz, Rudi Hrncic, et al.. (2001). Chemical Typing of Amyloid Protein Contained in Formalin-Fixed Paraffin-Embedded Biopsy Specimens. American Journal of Clinical Pathology. 116(1). 135–142. 102 indexed citations
9.
Westermark, Gunilla T., et al.. (2001). Distribution of medin-amyloid in aging and in association with arterial diseases. Amyloid. 8. 122–123. 3 indexed citations
10.
Ma, Zhi, Per Westermark, & Gunilla T. Westermark. (2000). Amyloid in Human Islets of Langerhans: Immunologic Evidence That Islet Amyloid Polypeptide Is Modified in Amyloidogenesis. Pancreas. 21(2). 212–218. 14 indexed citations
11.
Olsen, Karen Ege, Knut Sletten, & Per Westermark. (1998). Fragments of the Constant Region of Immunoglobulin Light Chains Are Constituents of AL-Amyloid Proteins. Biochemical and Biophysical Research Communications. 251(2). 642–647. 47 indexed citations
12.
13.
Westermark, Per. (1998). The pathogenesis of amyloidosis: understanding general principles [comment]. American Journal Of Pathology. 152. 3 indexed citations
14.
Westermark, Per. (1996). Diagnosing amyloidosis [editorial]. Scandinavian Journal of Rheumatology. 24. 327. 19 indexed citations
15.
Johnson, Kenneth H., K Sletten, David W. Hayden, et al.. (1995). AA amyloidosis in Chinese Shar-pei dogs: Immunohistochemical and amino acid sequence analyses. Amyloid. 2(2). 92–99. 15 indexed citations
16.
Westermark, Per, Décio L. Eizirik, Daniël Pipeleers, C. Hellerstr�m, & Arne Andersson. (1995). Rapid deposition of amyloid in human islets transplanted into nude mice. Diabetologia. 38(5). 543–549. 6 indexed citations
17.
Westermark, Per, Kenneth H. Johnson, Timothy D. O’Brien, & Christer Betsholtz. (1992). Islet amyloid polypeptide ? a novel controversy in diabetes research. Diabetologia. 35(4). 297–303. 91 indexed citations
18.
Cornwell, Gibbons G., Knut Sletten, B O Olofsson, B. Johansson, & Per Westermark. (1987). Prealbumin: its association with amyloid.. Journal of Clinical Pathology. 40(2). 226–231. 23 indexed citations
19.
Michaëlsson, G, Erik Olsson, & Per Westermark. (1981). The Rombo syndrome: a familial disorder with vermiculate atrophoderma, milia, hypotrichosis, trichoepitheliomas, basal cell carcinomas and peripheral vasodilation with cyanosis. Acta Dermato Venereologica. 61(6). 497–503. 84 indexed citations
20.
Westermark, Per, Lars Grimelius, J.M. Polak, et al.. (1977). Amyloid in polypeptide hormone-producing tumors.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 37(2). 212–5. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Phillip Görden Breakdown of academic impact, for papers by Enrique Rozengurt Breakdown of academic impact, for papers by Dudley K. Strickland Breakdown of academic impact, for papers by Axel Kahn Breakdown of academic impact, for papers by Shaun R. Coughlin Breakdown of academic impact, for papers by Roger J. Hajjar Breakdown of academic impact, for papers by Gunilla T. Westermark Breakdown of academic impact, for papers by Peter J. Parker Breakdown of academic impact, for papers by Jan M. van Deursen Breakdown of academic impact, for papers by Edward J. Goetzl
Rankless by CCL
2026